Rite Aid Corporation (RAD) : 1 brokerage houses believe that Rite Aid Corporation (RAD) is a Strong Buy at current levels. 3 analysts believe that the current prices are in a balance with the stocks fundamentals, hence they propose Hold on Rite Aid Corporation (RAD). Zacks Investment Research suggests a Hold with a rank of 3.The median of all the 4 Wall Street Analysts endorse the stock as a Buy with a rating of 2.5.
Rite Aid Corporation (RAD) : Average target price received by Rite Aid Corporation (RAD) is $9.25 with an expected standard deviation of $0.5. The most aggressive target on the stock is $10, whereas the most downbeat target is $9. 4 financial analysts are currently covering the stock.
Rite Aid Corporation (NYSE:RAD): The stock opened in the green at $8.1 on Thursday, but the bulls found it difficult to push the prices higher. The stock reached a high of $8.12 and a low of $7.99 for the day. The stock did not find buyers even at the lows and closed at $8.06 recording a loss of -0.25%. 17,690,209 shares exchanged hands during the trading day. The stock had closed at $8.08 in the previous days trading.
Rite Aid Corporation is a retail drugstore chain. The Company sells prescription drugs and a range of other merchandise, which are referred to as front-end products. The Companys drugstores primary business is pharmacy services. It operates approximately 4,570 stores in 31 states across the country and in the District of Columbia. Its front-end products include over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise and various other every day and convenience products. The Company offers a range of products through its portfolio of private brands. Its classes of products include prescription drugs, over-the-counter medications and personal care, health and beauty aids, and general merchandise and other. It sells private brand and co-branded products. It operates under The Rite Aid name.